Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Carlo Antozzi & Renato Mantegazza. (2023) Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis. Patient Related Outcome Measures 14, pages 305-312.
Read now
Read now
Sruthi S Nair & Saiju Jacob. (2023) Novel Immunotherapies for Myasthenia Gravis. ImmunoTargets and Therapy 12, pages 25-45.
Read now
Read now
Shigeaki Suzuki, Akiyuki Uzawa & Hiroyuki Murai. (2022) Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective. Expert Review of Clinical Immunology 18:12, pages 1207-1215.
Read now
Read now
Jéssica Barreto Ribeiro Dos Santos, Rosângela Maria Gomes & Michael Ruberson Ribeiro da Silva. (2022) Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience. Expert Review of Clinical Immunology 18:9, pages 879-888.
Read now
Read now
Panos Stathopoulos & Marinos C Dalakas. (2022) The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders. Expert Review of Clinical Immunology 18:9, pages 933-945.
Read now
Read now
Articles from other publishers (5)
Kazuo Iwasa, Yutaka Furukawa, Hiroaki Yoshikawa, Masahito Yamada & Kenjiro Ono. (2022) CD59 Expression in Skeletal Muscles and Its Role in Myasthenia Gravis. Neurology - Neuroimmunology Neuroinflammation 10:1, pages e200057.
Crossref
Crossref
Huahua Zhong, Zhe Ruan, Chong Yan, Zhiguo Lv, Xueying Zheng, Li-Ying Goh, Jianying Xi, Jie Song, Lijun Luo, Lan Chu, Song Tan, Chao Zhang, Bitao Bu, Yuwei Da, Ruisheng Duan, Huan Yang, Sushan Luo, Ting Chang & Chongbo Zhao. (2023) Short-term outcome prediction for myasthenia gravis: an explainable machine learning model. Therapeutic Advances in Neurological Disorders 16, pages 175628642311549.
Crossref
Crossref
Cynthia Z. Qi, Tom Hughes, Deborah Gelinas, Yuebing Li, Amit Goyal, Edward Brauer, Arpit Bhuwalka, Mai Sato, Sudhir Jadhav & Glenn Phillips. (2022) Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United States. Journal of the Neurological Sciences 443, pages 120480.
Crossref
Crossref
Daniel Sánchez-Tejerina, Javier Sotoca, Arnau Llaurado, Veronica López-Diego, Raul Juntas-Morales & Maria Salvado. (2022) New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies. Journal of Clinical Medicine 11:21, pages 6394.
Crossref
Crossref
Silvia Attardo, Olimpia Musumeci, Daniele Velardo & Antonio Toscano. (2022) Statins Neuromuscular Adverse Effects. International Journal of Molecular Sciences 23:15, pages 8364.
Crossref
Crossref